UNITY Biotechnology, Inc. to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference June 5, 2018 at 4:05 PM EDT PDF Version SAN FRANCISCO, June 05, 2018 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (NASDAQ:UBX), a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that Keith Leonard, chairman and chief executive officer, will discuss the company during a fireside chat at the Goldman Sachs 39th Annual Global Healthcare Conference on Wednesday, June 13, 2018, at 4:00 p.m. PT. A live audio webcast will be available through the Investors and Media section of UNITY’s website. An archived replay will be available for 90 days following the event. About UNITY BiotechnologyUNITY Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter. Investors UNITY Biotechnology, Inc.Bob Goeltz Chief Financial Officer 1-650-525-4980 email@example.com Media Canale CommunicationsJason Spark 1-619-849-6005 firstname.lastname@example.org Source: Unity Biotechnology, Inc.